TENTATIVE SCHEDULE - Sunday, September 23
Non-CME Networking Featured
7:30am - 5:00pm Registration Desk Open
8:00am - 8:30am Coffee Break with Exhibitors
8:30am - 9:00am Welcome and Opening Remarks
9:00am - 10:00am Plenary 1: Variations in cancer risk: Cristian Tomasetti
10:00am - 10:15am Coffee Break With Exhibitors
10:15am - 12:15pm

S1: Radiation-induced GI Syndrome
- What is old is new again: normal tissue radioprotectors to enable ablative radiation in the abdomen: Cullen Taniguchi
- Protection against radiation-induced intestinal injury, a matter of p53: Jian Yu
  S2: Radiation dosimetry: in patients and phantoms
- Dosimetry for advanced small animal radiation therapy: What's Achievable?: Mark Oldham
- Cherenkov and scintillation imaging in radiotherapy for quantitative dosimetry and molecular sensing: Brian Pogue
  S3: Mechanisms of cell death after radiation
- Radiation-induced apoptosis in healthy tissues and cancers: Kristopher Sarosiek
Senescent cells are new targets for cancer and radiation-induced late effects: Daohong Zhou
  S4: Hypofractionation: from pre-clinical models to clinical trials
- Hypofractionation with particle therapy: Tadashi Kamada
- Optimising radiotherapy fractionation - from clinical trials to molecular mechanisms: Navita Somaiah

  S5: Genomics of normal tissue toxicity and tumor response to radiation
- Genomic analysis of tumor resonse to DNA damaging therapies: Kent Mouw
- Systematic characterization of the associations between the cancer genome and ionizing radiation: Mohamed Abazeed
12:15pm - 1:45pm SIT Mentor Lunch (SITs Only, RSVP Required)
1:45pm - 2:30pm Poster Session 1
2:30pm - 3:15pm Poster Session 2
3:15pm - 5:15pm

S6: Hypoxia and ER stress
- Targeting the UPR and ISR to improve response to radiotherapy: Constantinos Koumenis
- ROS metabolism in the ER as a novel cancer target: Marianne Koritzinsky
  S7: Imaging and circulating biomarkers of radiation response
- Analysis of circulating tumor DNA for detection of molecular residual disease after radiotherapy: Max Diehn
- Circulating tumor cells as a biomarker for radiation treatment response and tumor surveillance: Andrew Wang
  S8: Radionuclides for imaging, therapy and dosimetry
- PSMA-targeted radiopharmaceutical therapy for prostate cancer: Ana Ponce Kiess
- Cancer imaging biomarkers to guide targeted cancer therapy: David Mankoff
- Targeted radionuclide therapy: the promise of alpha-emitters: Rebecca Abergel
  S9: Chromatin biology and radiation response
- Reorganizing chromatin during DSB repair: Brendan Price
- Post-translational chromatin modifications: The therapeutic potential: Tej Pandita
  S10: (Joint Session- CRH) Space radiation and cancer risk
- Approaches to understanding space radiation cancer risks: Mike Weil
- Associating DNA repair deficiency to radiation-induced cancer and genetic factors in mice and humans: Sylvain Costes
5:15pm - 5:30pm Coffee Break with Exhibitors
5:30pm - 6:30pm Failla Lecture
6:30pm - 8:45pm Welcome Reception (RSVP Required)
8:30pm - 11:30pm Karaoke

380 Ice Center Lane, Suite C | Bozeman, MT 59718 | 1.877.216.1919
Member & Exhibitor Services: Audrey Rinehart |
1.877.216.1919  |